247 related articles for article (PubMed ID: 17390084)
1. A study of innate immunity in patients with end-stage renal disease: special reference to toll-like receptor-2 and -4 expression in peripheral blood monocytes of hemodialysis patients.
Kuroki Y; Tsuchida K; Go I; Aoyama M; Naganuma T; Takemoto Y; Nakatani T
Int J Mol Med; 2007 May; 19(5):783-90. PubMed ID: 17390084
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte toll-like receptor expression in end-stage kidney disease.
Gollapudi P; Yoon JW; Gollapudi S; Pahl MV; Vaziri ND
Am J Nephrol; 2010; 31(3):247-54. PubMed ID: 20090311
[TBL] [Abstract][Full Text] [Related]
3. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
[TBL] [Abstract][Full Text] [Related]
4. Changes in Toll-like receptor (TLR)-2 and TLR4 expression and function but not polymorphisms are associated with acute anterior uveitis.
Chang JH; Hampartzoumian T; Everett B; Lloyd A; McCluskey PJ; Wakefield D
Invest Ophthalmol Vis Sci; 2007 Apr; 48(4):1711-7. PubMed ID: 17389503
[TBL] [Abstract][Full Text] [Related]
5. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?
Candia L; Marquez J; Hernandez C; Zea AH; Espinoza LR
J Rheumatol; 2007 Feb; 34(2):374-9. PubMed ID: 17183618
[TBL] [Abstract][Full Text] [Related]
6. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
[TBL] [Abstract][Full Text] [Related]
7. Toll-like receptor 2 and 4 expression after severe injury is not involved in the dysregulation of the innate immune system.
Lendemans S; Kreuzfelder E; Rani M; Bayeeh E; Schade FU; Flohé SB; Waydhas C; Flohé S
J Trauma; 2007 Oct; 63(4):740-6. PubMed ID: 18089999
[TBL] [Abstract][Full Text] [Related]
8. Toll-like receptor expression in monocytes in patients with chronic kidney disease and haemodialysis: relation with inflammation.
Koc M; Toprak A; Arikan H; Odabasi Z; Elbir Y; Tulunay A; Asicioglu E; Eksioglu-Demiralp E; Glorieux G; Vanholder R; Akoglu E
Nephrol Dial Transplant; 2011 Mar; 26(3):955-63. PubMed ID: 20729266
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor 2 and 4 response and expression on monocytes decrease rapidly in patients undergoing arterial surgery and are related to preoperative smoking.
Versteeg D; Dol E; Hoefer IE; Flier S; Buhre WF; de Kleijn D; van Dongen EP; Pasterkamp G; de Vries JP
Shock; 2009 Jan; 31(1):21-7. PubMed ID: 18650783
[TBL] [Abstract][Full Text] [Related]
10. Glutamine as a modulator of the immune system of critical care patients: effect on Toll-like receptor expression. A preliminary study.
Pérez-Bárcena J; Regueiro V; Marsé P; Raurich JM; Rodríguez A; Ibáñez J; de Lorenzo Mateos AG; Bengoechea JA
Nutrition; 2008 Jun; 24(6):522-7. PubMed ID: 18367379
[TBL] [Abstract][Full Text] [Related]
11. Polybacterial immunomodulator Respivax restores the inductive function of innate immunity in patients with recurrent respiratory infections.
Nikolova M; Stankulova D; Taskov H; Nenkov P; Maximov V; Petrunov B
Int Immunopharmacol; 2009 Apr; 9(4):425-32. PubMed ID: 19186221
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.
Honda Y; Yamagiwa S; Matsuda Y; Takamura M; Ichida T; Aoyagi Y
J Hepatol; 2007 Sep; 47(3):404-11. PubMed ID: 17448566
[TBL] [Abstract][Full Text] [Related]
13. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis.
Mao TK; Lian ZX; Selmi C; Ichiki Y; Ashwood P; Ansari AA; Coppel RL; Shimoda S; Ishibashi H; Gershwin ME
Hepatology; 2005 Oct; 42(4):802-8. PubMed ID: 16175622
[TBL] [Abstract][Full Text] [Related]
14. HLA-DR expression and apoptosis: a cross-sectional controlled study in hemodialysis and peritoneal dialysis patients.
de Cal M; Cruz DN; Corradi V; Nalesso F; Polanco N; Lentini P; Brendolan A; Tetta C; Ronco C
Blood Purif; 2008; 26(3):249-54. PubMed ID: 18376106
[TBL] [Abstract][Full Text] [Related]
15. Expression of toll-like receptors 2 and 4 is upregulated during hospital admission in traumatic patients: lack of correlation with blunted innate immune responses.
Pérez-Bárcena J; Regueiro V; Crespí C; Pierola J; Oliver A; Llompart-Pou JA; Ayestarán JI; Raurich JM; Marsé P; Ibáñez J; Bengoechea JA
Ann Surg; 2010 Mar; 251(3):521-7. PubMed ID: 20134316
[TBL] [Abstract][Full Text] [Related]
16. Expression of Toll-like receptors 2 and 4 on innate immunity cells modulated by cardiac surgical operation.
Krejsek J; Kunes P; Kolackova M; Kudlova M; Lonsky V; Mandak J; Andrys C
Scand J Clin Lab Invest; 2008; 68(8):749-58. PubMed ID: 19061090
[TBL] [Abstract][Full Text] [Related]
17. Differential toll-like receptor expression after ex vivo lipopolysaccharide exposure in patients with sepsis and following surgical stress.
Tsujimoto H; Ono S; Majima T; Efron PA; Kinoshita M; Hiraide H; Moldawer LL; Mochizuki H
Clin Immunol; 2006 May; 119(2):180-7. PubMed ID: 16517212
[TBL] [Abstract][Full Text] [Related]
18. Increased mucosal expression of Toll-like receptor (TLR)2 and TLR4 in coeliac disease.
Szebeni B; Veres G; Dezsofi A; Rusai K; Vannay A; Bokodi G; Vásárhelyi B; Korponay-Szabó IR; Tulassay T; Arató A
J Pediatr Gastroenterol Nutr; 2007 Aug; 45(2):187-93. PubMed ID: 17667714
[TBL] [Abstract][Full Text] [Related]
19. Fluvastatin reduces increased blood monocyte Toll-like receptor 4 expression in whole blood from patients with chronic heart failure.
Földes G; von Haehling S; Okonko DO; Jankowska EA; Poole-Wilson PA; Anker SD
Int J Cardiol; 2008 Feb; 124(1):80-5. PubMed ID: 17383753
[TBL] [Abstract][Full Text] [Related]
20. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation.
Kim KW; Cho ML; Lee SH; Oh HJ; Kang CM; Ju JH; Min SY; Cho YG; Park SH; Kim HY
Immunol Lett; 2007 May; 110(1):54-64. PubMed ID: 17467812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
